HIV Gene Therapy

G-CSF Use Applicable In HIV Gene Therapies, Immunotherapies, and Antiretroviral

Published in AIDS Weekly, August 24th, 1998

Because granulocyte colony-stimulating factor (G-CSF) administration increases the numbers of naive CD4 and CD34 cells in HIV infected patients, it may have broad use in immunotherapy, gene therapy and antiretroviral therapy protocols for these patients.

Susanne D. Nielsen and colleagues from the Hvidovre Hospital and the Retrovirus Laboratory, Denmark, examined the potential of G-CSF for use in gene/immunotherapies or for support in antiretroviral therapies in HIV infected patients ("Effect of Granulocyte Colony-Stimulating Factor (G-CSF) in Human Immunodeficiency Virus (HIV) Infected Patients: Increase in Numbers of Naive CD4 Cells and CD34 Cells Makes G-CSF a...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (1998-08-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry